MedTrace Logo

Bronchoalveolar Lavage in Recovered From COVID-19 Pneumonia

NCT06022198 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-09-01

No results posted yet for this study

Summary

Coronaviruses such as SARS-CoV2, MERS-CoV, and SARS-CoV can cause significant morbidity and mortality in infected persons. Lung is the most common site of infection for these viruses, which may manifest as acute respiratory distress syndrome and mortality. Pulmonary involvement is also responsible for the high viral transmission The aim of this study is to evaluate BAL in post-acute COVID-19 patients for:Cytological and cellular patterns. Microbial analysis for possibility of presence of bacterial, mycobacerial or fungal co-infection.PCR for corona virus

Conditions

  • Bronchoalveolar Lavage

Interventions

PROCEDURE

Bronchoalveolar Lavage

Bronchoalveolar Lavage

Sponsors & Collaborators

  • Marwa Salah Abdelrazek Ghanem

    collaborator UNKNOWN

  • Mohammad Khairy El-Badrawy

    collaborator UNKNOWN

  • Tamer Ali Elhadidy

    collaborator UNKNOWN

  • Dalia Abdellateif Abdelghany

    collaborator UNKNOWN

  • Mohamed Abd Elmoniem Mohamed

    lead OTHER

Principal Investigators

  • Marwa Ghanem · Mansoura university Faculty of medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2023-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06022198 on ClinicalTrials.gov